Avalon Technologies IPO vs Mankind Pharma IPO

Comparision between Avalon Technologies IPO and Mankind Pharma IPO.

IPO Details

Avalon Technologies IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Mankind Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Avalon Technologies IPO	Mankind Pharma IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	Jm Financial Limited Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) Iifl Securities Ltd Nomura Financial Advisory And Securities (India) Pvt Ltd	Kotak Mahindra Capital Company Limited Axis Capital Limited Iifl Securities Ltd Jefferies India Private Limited J.P. Morgan India Private Limited
Registrar	Link Intime India Private Ltd	Kfin Technologies Limited
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Avalon Technologies IPO is up to ₹865.00 Cr whereas the issue size of the Mankind Pharma IPO is up to ₹4,326.36 Cr. The final issue price of Avalon Technologies IPO is ₹436.00 per share and of Mankind Pharma IPO is ₹1,080.00 per share.

	Avalon Technologies IPO	Mankind Pharma IPO
Face Value	₹2 per share	₹1 per share
Issue Price (Lower)	₹415.00 per share	₹1,026.00 per share
Issue Price (Upper)	₹436.00 per share	₹1,080.00 per share
Issue Price (Final)	₹436.00 per share	₹1,080.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	34 shares	13 shares
Fresh Issue Size	73,39,450 shares
Fresh Issue Size (Amount)	up to ₹320.00 Cr
OFS Issue Size	1,25,00,000 shares	4,00,58,844 shares
OFS Issue Size (Amount)	up to ₹545.00 Cr	up to ₹4,326.36 Cr
Issue Size Total	1,98,39,450 shares	4,00,58,844 shares
Issue Size Total (Amount)	up to ₹865.00 Cr	up to ₹4,326.36 Cr

IPO Timetable

Avalon Technologies IPO opens on Apr 03, 2023, while Mankind Pharma IPO opens on Apr 25, 2023. The closing date of Avalon Technologies IPO and Mankind Pharma IPO is Apr 06, 2023, and Apr 27, 2023, respectively.

	Avalon Technologies IPO	Mankind Pharma IPO
Anchor Bid Date	Mar 31, 2023	Apr 24, 2023
Issue Open	Apr 03, 2023	Apr 25, 2023
Issue Close	Apr 06, 2023	Apr 27, 2023
Basis Of Allotment (Tentative)	Apr 12, 2023	May 03, 2023
Initiation of Refunds (Tentative)	Apr 13, 2023	May 04, 2023
Credit of Share (Tentative)	Apr 17, 2023	May 05, 2023
Listing date (Tentative)	Apr 18, 2023	May 09, 2023
Anchor Lockin End date 1	May 12, 2023	Jun 02, 2023
Anchor Lockin End date 2	Jul 11, 2023	Aug 01, 2023

Financials

Avalon Technologies IPO P/E ratio is 55.54, as compared to Mankind Pharma IPO P/E ratio of 32.5.

Avalon Technologies IPO

Mankind Pharma IPO

Financial

Avalon Technologies Limited Financial Information (Restated Consolidated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Total Borrowing
31-Mar-20	449.65	653.15	12.33	248.48
31-Mar-21	512.48	695.90	23.08	295.33
31-Mar-22	587.96	851.65	68.16	294.05
Amount in ₹ Crore

Mankind Pharma Limited Financial Information (Restated Consolidated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth	Reserves and Surplus	Total Borrowing
31-Mar-20	5,073.29	5,975.65	1,056.15	3,485.31	3,436.34	126.92
31-Mar-21	6,372.63	6,385.38	1,293.03	4,722.00	4,674.39	234.53
31-Dec-21	8,043.88	6,218.29	1,260.24	5,965.46	5,916.86	268.70
31-Mar-22	9,147.74	7,977.58	1,452.96	6,155.23	6,106.06	868.03
31-Dec-22	9,273.75	6,777.82	1,015.98	7,145.89	7,094.12	167.93
Amount in ₹ Crore

Promoter Shareholding (Pre-Issue)

70.75%

79.00%

Promoter Shareholding (Post-Issue)

51.24%

76.50%

P/E Ratio

55.54

32.5

Market Cap

₹2846.76 Cr.

₹43263.60 Cr.

ROE

85.90%%

27.60%%

ROCE

27.40%%

26.10%%

Debt/Equity

3.64

EPS

₹33.20

RoNW

27.70%%

Shares Offered

In the Avalon Technologies IPO retail investors (RII) are offered 19,83,944 shares while in Mankind Pharma IPO retail investors are offered 19,83,944 shares. Qualified institutional buyers (QIB) are offered 59,15,011 shares in Avalon Technologies IPO and 80,11,769 shares in Mankind Pharma IPO.

	Avalon Technologies IPO	Mankind Pharma IPO
Anchor Investor Reserveration	89,27,751 shares	1,20,17,652 shares
Market Maker Reserveration
QIB	59,15,011 shares	80,11,769 shares
NII	29,75,917 shares	60,08,827 shares
RII	19,83,944 shares	1,40,20,596 shares
Employee	0 shares	0 shares
Others
Total	1,08,44,186 shares	2,80,41,192 shares

Bids Received (Subscription)

Avalon Technologies IPO subscribed 2.34x in total, whereas Mankind Pharma IPO subscribed 15.32x.

	Avalon Technologies IPO	Mankind Pharma IPO
QIB (times)	3.77x	49.16x
NII (times)	0.43x	3.80x
Big NII (times)	0.44x	4.99x
Small NII (times)	0.41x	1.41x
RII (times)	0.88x	0.92x
Employee (times)
Other (times)
Total (times)	2.34x	15.32x

Compare with others

Avalon Technologies IPO	Mankind Pharma IPO
HMA Agro Industries IPO	ideaForge Technology IPO
IKIO Lighting IPO	HMA Agro Industries IPO
Tata Technologies IPO	IKIO Lighting IPO
Nexus Select Trust REIT	Tata Technologies IPO
Mankind Pharma IPO	Nexus Select Trust REIT
Udayshivakumar Infra IPO	Avalon Technologies IPO
Global Surfaces IPO	Udayshivakumar Infra IPO
Divgi TorqTransfer Systems IPO	Global Surfaces IPO
Signatureglobal India IPO	Divgi TorqTransfer Systems IPO
Radiant Cash Management IPO	Signatureglobal India IPO

Comments

Add a public comment...